| PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein T Mochizuki, G Wu, T Hayashi, SL Xenophontos, B Veldhuisen, JJ Saris, ... Science 272 (5266), 1339-1342, 1996 | 1778 | 1996 |
| microRNAs: a newly described class of encoded molecules that play a role in health and disease K Felekkis, E Touvana, C Stefanou, C Deltas Hippokratia 14 (4), 236, 2010 | 544 | 2010 |
| An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy NJH Sharp, JN Kornegay, SD Van Camp, MH Herbstreith, SL Secore, ... Genomics 13 (1), 115-121, 1992 | 448 | 1992 |
| Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis DP Gale, EG De Jorge, HT Cook, R Martinez-Barricarte, A Hadjisavvas, ... The Lancet 376 (9743), 794-801, 2010 | 391 | 2010 |
| Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management—a KDIGO consensus report KU Eckardt, SL Alper, C Antignac, AJ Bleyer, D Chauveau, K Dahan, ... Kidney international 88 (4), 676-683, 2015 | 369 | 2015 |
| Chromosome 4 localization of a second gene for autosomal dominant polycystic kidney disease DJM Peters, L Spruit, JJ Saris, D Ravine, LA Sandkuijl, R Fossdal, ... Nature genetics 5 (4), 359-362, 1993 | 361 | 1993 |
| COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy K Voskarides, L Damianou, V Neocleous, I Zouvani, S Christodoulidou, ... Journal of the American Society of Nephrology 18 (11), 3004-3016, 2007 | 252 | 2007 |
| Expert consensus guidelines for the genetic diagnosis of Alport syndrome J Savige, F Ariani, F Mari, M Bruttini, A Renieri, O Gross, C Deltas, ... Pediatric Nephrology 34, 1175-1189, 2019 | 179 | 2019 |
| Small molecule targets TMED9 and promotes lysosomal degradation to reverse proteinopathy M Dvela-Levitt, M Kost-Alimova, M Emani, E Kohnert, R Thompson, ... Cell 178 (3), 521-535. e23, 2019 | 174 | 2019 |
| Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees Y Athanasiou, K Voskarides, DP Gale, L Damianou, C Patsias, M Zavros, ... Clinical Journal of the American Society of Nephrology 6 (6), 1436-1446, 2011 | 174 | 2011 |
| Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta. LD Spotila, CD Constantinou, L Sereda, A Ganguly, BL Riggs, ... Proceedings of the National Academy of Sciences 88 (12), 5423-5427, 1991 | 168 | 1991 |
| Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes … A Pierides, K Voskarides, Y Athanasiou, K Ioannou, L Damianou, M Arsali, ... Nephrology Dialysis Transplantation 24 (9), 2721-2729, 2009 | 160 | 2009 |
| Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease R Magistroni, N He, K Wang, R Andrew, A Johnson, P Gabow, E Dicks, ... Journal of the American Society of Nephrology 14 (5), 1164-1174, 2003 | 158 | 2003 |
| Chromosome 1 localization of a gene for autosomal dominant medullary cystic kidney disease (ADMCKD) K Christodoulou, M Tsingis, C Stavrou, A Eleftheriou, P Papapavlou, ... Human molecular genetics 7 (5), 905-911, 1998 | 156 | 1998 |
| Germinal and Somatic Mutations in the PKD2 Gene of Renal Cysts in Autosomal Dominant Polycystic Kidney Disease M Koptides, C Hadjimichael, P Koupepidou, A Pierides, CC Deltas Human molecular genetics 8 (3), 509-513, 1999 | 142 | 1999 |
| Genetic evidence for a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease M Koptides, R Mean, K Demetriou, A Pierides, CC Deltas Human molecular genetics 9 (3), 447-452, 2000 | 132 | 2000 |
| Mutation analysis of coding sequences for type I procollagen in individuals with low bone density LD Spotila, A Colige, L Sereda, CD Constantinou‐Deltas, MP Whyte, ... Journal of Bone and Mineral Research 9 (6), 923-932, 1994 | 131 | 1994 |
| A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics C Mizzi, E Dalabira, J Kumuthini, N Dzimiri, I Balogh, N Başak, R Böhm, ... PloS one 11 (9), e0162866, 2016 | 126 | 2016 |
| Type I procollagen: The gene‐protein system that harbors most of the mutations causing osteogenesis imperfecta and probably more common heritable disorders of connective tissue DJ Prockop, CD Constantinou, KE Dombrowski, Y Hojima, KE Kadler, ... American journal of medical genetics 34 (1), 60-67, 1989 | 118 | 1989 |
| Guidelines for genetic testing and management of Alport syndrome J Savige, BS Lipska-Zietkiewicz, E Watson, JM Hertz, C Deltas, F Mari, ... Clinical Journal of the American Society of Nephrology 17 (1), 143-154, 2022 | 117 | 2022 |
